178 related articles for article (PubMed ID: 10353828)
1. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
2. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
3. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
4. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
5. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
Nyholm PG; Brunton JL; Lingwood CA
Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
[TBL] [Abstract][Full Text] [Related]
6. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
[TBL] [Abstract][Full Text] [Related]
7. Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins.
Nyholm PG; Magnusson G; Zheng Z; Norel R; Binnington-Boyd B; Lingwood CA
Chem Biol; 1996 Apr; 3(4):263-75. PubMed ID: 8807854
[TBL] [Abstract][Full Text] [Related]
8. Modeling the carbohydrate-binding specificity of pig edema toxin.
Cummings MD; Ling H; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1789-99. PubMed ID: 9485304
[TBL] [Abstract][Full Text] [Related]
9. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization.
Khine AA; Lingwood CA
J Cell Physiol; 1994 Nov; 161(2):319-32. PubMed ID: 7962116
[TBL] [Abstract][Full Text] [Related]
10. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
11. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.
Arab S; Lingwood CA
Glycoconj J; 1996 Apr; 13(2):159-66. PubMed ID: 8737240
[TBL] [Abstract][Full Text] [Related]
12. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the complex between the B-subunit homopentamer of verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide.
Shimizu H; Field RA; Homans SW; Donohue-Rolfe A
Biochemistry; 1998 Aug; 37(31):11078-82. PubMed ID: 9693003
[TBL] [Abstract][Full Text] [Related]
14. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
Nutikka A; Lingwood C
Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
[TBL] [Abstract][Full Text] [Related]
15. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Mylvaganam M; Lingwood CA
Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
[TBL] [Abstract][Full Text] [Related]
16. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
17. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
18. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
Heath-Engel HM; Lingwood CA
Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.
Stein PE; Boodhoo A; Tyrrell GJ; Brunton JL; Read RJ
Nature; 1992 Feb; 355(6362):748-50. PubMed ID: 1741063
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]